NHL
Clinical trials for NHL explained in plain language.
Never miss a new study
Get alerted when new NHL trials appear
Sign up with your email to follow new studies for NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new pill combo aims to boost lymphoma cure rates
⭐️ CURE ⭐️ Recruiting nowThis study tests whether adding the drug acalabrutinib to standard chemotherapy can cure more people with untreated diffuse large B-cell lymphoma, an aggressive blood cancer. About 132 adults will take the pill twice daily for up to 14 days, then receive standard chemo and rituxi…
Matched conditions: NHL
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️
Last updated May 18, 2026 12:13 UTC
-
New pill hopes to tame Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-stage study tests an experimental tablet, HSK47977, in adults whose Non-Hodgkin's lymphoma has returned or stopped responding to treatment. The main goals are to find the safest dose and check how well the drug works. About 110 participants will take part over roughly …
Matched conditions: NHL
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 09:04 UTC
-
Yoga and mindfulness may boost health in cancer survivors
Symptom relief Recruiting nowThis study looks at whether yoga and mindfulness can improve the emotional, social, and physical well-being of people who have survived lung, colon, or non-Hodgkin's lymphoma cancer. Researchers will also check if these practices affect inflammation and gene activity. About 100 a…
Matched conditions: NHL
Phase: NA • Sponsor: Barbara Nemesure • Aim: Symptom relief
Last updated May 26, 2026 09:04 UTC